T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Fastenal
FAST
$58.9B
| $54M | 0.01% |
2,148,244
-130,536
| -6% | -$3.12M |
|
977
Unity
U
$20.2B
| $53.9M | 0.01% |
+537,317
| New | +$66.2M |
|
|
RDFN
978
DELISTED
Redfin
RDFN
| $53.9M | 0.01% |
809,099
+7,430
| +0.9% | +$567K |
|
979
Stanley Black & Decker
SWK
$15.4B
| $53.8M | 0.01% |
269,614
-1,335,657
| -83% | -$242M |
|
|
CELL
980
DELISTED
PhenomeX Inc. Common Stock
CELL
| $53.6M | 0.01% |
1,067,689
+605,392
| +131% | +$41.3M |
|
981
Eastern Bankshares
EBC
$5.37B
| $53.3M | 0.01% |
2,760,744
+90,524
| +3% | +$1.57M |
|
982
Globus Medical
GMED
$11.5B
| $53.2M | 0.01% |
863,318
-15,907
| -2% | -$1.01M |
|
983
Atkore
ATKR
$3.17B
| $53.2M | 0.01% |
740,166
-350,655
| -32% | -$21.2M |
|
984
Albany International
AIN
$1.82B
| $52.8M | 0.01% |
632,187
-12,500
| -2% | -$991K |
|
985
Sarepta Therapeutics
SRPT
$1.95B
| $52.5M | 0.01% |
704,153
-598,498
| -46% | -$55.2M |
|
986
Walker & Dunlop
WD
$1.47B
| $52.4M | 0.01% |
510,327
+3,166
| +0.6% | +$308K |
|
|
DCPH
987
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $52.4M | 0.01% |
1,168,268
-6,624
| -0.6% | -$308K |
|
|
REVHU
988
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
| $52.3M | 0.01% |
+5,200,000
| New | +$52.2M |
|
989
Relay Therapeutics
RLAY
$4.37B
| $52M | 0.01% |
1,505,092
+731,517
| +95% | +$31.7M |
|
990
Q2 Holdings
QTWO
$4.13B
| $52M | 0.01% |
519,112
-1,380,655
| -73% | -$172M |
|
991
Take-Two Interactive
TTWO
$45.2B
| $51.9M | 0.01% |
293,942
-14,123
| -5% | -$2.68M |
|
992
Lennar Class A
LEN
$21.1B
| $51.8M | 0.01% |
528,679
-3,242,678
| -86% | -$273M |
|
993
Kinder Morgan
KMI
$71.4B
| $51.5M | 0.01% |
3,095,223
-208,249
| -6% | -$3.18M |
|
994
Healthcare Realty
HR
$6.58B
| $51.4M | 0.01% |
1,864,442
+45,852
| +3% | +$1.28M |
|
995
Blue Bird Corp
BLBD
$2.05B
| $51.3M | 0.01% |
2,047,898
-6,880
| -0.3% | -$157K |
|
|
DFS
996
DELISTED
Discover Financial Services
DFS
| $51M | 0.01% |
537,198
-30,862
| -5% | -$2.91M |
|
997
Archer Daniels Midland
ADM
$38.6B
| $51M | 0.01% |
894,690
-56,254
| -6% | -$3.09M |
|
998
J&J Snack Foods
JJSF
$1.7B
| $50.8M | 0.01% |
323,793
-12,764
| -4% | -$2M |
|
999
Essential Properties Realty Trust
EPRT
$6.71B
| $50.6M | 0.01% |
2,216,863
+553,404
| +33% | +$12.4M |
|
1000
Merit Medical Systems
MMSI
$5.4B
| $50.2M | 0.01% |
838,357
+62,074
| +8% | +$3.56M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.